Co-Authors
This is a "connection" page, showing publications co-authored by James Prisciandaro and Kathleen Brady.
Connection Strength
3.805
-
The relationship between years of cocaine use and brain activation to cocaine and response inhibition cues. Addiction. 2014 Dec; 109(12):2062-70.
Score: 0.486
-
Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):44-9.
Score: 0.447
-
Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):195-201.
Score: 0.442
-
Associations between behavioral disinhibition and cocaine use history in individuals with cocaine dependence. Addict Behav. 2012 Oct; 37(10):1185-8.
Score: 0.419
-
Brain activation to cocaine cues and motivation/treatment status. Addict Biol. 2014 Mar; 19(2):240-9.
Score: 0.414
-
Psychoticism and neuroticism predict cocaine dependence and future cocaine use via different mechanisms. Drug Alcohol Depend. 2011 Jul 01; 116(1-3):80-5.
Score: 0.382
-
Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial. Psychiatry Res. 2021 Jan; 295:112904.
Score: 0.180
-
Effects of yohimbine and drug cues on impulsivity and attention in cocaine-dependent men and women and sex-matched controls. Drug Alcohol Depend. 2016 May 01; 162:56-63.
Score: 0.136
-
Individualized real-time fMRI neurofeedback to?attenuate craving in nicotine-dependent smokers. J Psychiatry Neurosci. 2016 Jan; 41(1):48-55.
Score: 0.134
-
D-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependence. Am J Addict. 2015 Apr; 24(3):217-224.
Score: 0.127
-
Real-time fMRI in the treatment of nicotine dependence: a conceptual review and pilot studies. Psychol Addict Behav. 2013 Jun; 27(2):501-9.
Score: 0.104
-
A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Bipolar Disord. 2012 Feb; 14(1):54-63.
Score: 0.102
-
Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate. Alcohol Clin Exp Res. 2012 Mar; 36(3):490-6.
Score: 0.100
-
Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial. Psychiatry Res. 2011 Aug 15; 188(3):361-5.
Score: 0.098
-
Predictors of clinical trial dropout in individuals with co-occurring bipolar disorder and alcohol dependence. Drug Alcohol Depend. 2011 Nov 01; 118(2-3):493-6.
Score: 0.097
-
N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A?preliminary randomized clinical trial. Neuropsychopharmacology. 2023 Mar 06.
Score: 0.055
-
Sustained reduction of nicotine craving with real-time neurofeedback: exploring the role of severity of dependence. Nicotine Tob Res. 2013 Dec; 15(12):2120-4.
Score: 0.028
-
Reduction of cue-induced craving through realtime neurofeedback in nicotine users: the role of region of interest selection and multiple visits. Psychiatry Res. 2013 Jul 30; 213(1):79-81.
Score: 0.028
-
Volitional reduction of anterior cingulate cortex activity produces decreased cue craving in smoking cessation: a preliminary real-time fMRI study. Addict Biol. 2013 Jul; 18(4):739-48.
Score: 0.026